Sitryx Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Sitryx Therapeutics's estimated annual revenue is currently $9.5M per year.
- Sitryx Therapeutics's estimated revenue per employee is $168,839
Employee Data
- Sitryx Therapeutics has 56 Employees.
- Sitryx Therapeutics grew their employee count by 56% last year.
Sitryx Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | CSO | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Head People & Culture | Reveal Email/Phone |
5 | Head Early Clinical Development | Reveal Email/Phone |
6 | Chief Scientific Officer at Sitryx | Reveal Email/Phone |
7 | Chief Medical Officer | Reveal Email/Phone |
8 | Associate Director Finance | Reveal Email/Phone |
9 | Chief Business Officer | Reveal Email/Phone |
10 | Associate Director Clinical Operations | Reveal Email/Phone |
Sitryx Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Sitryx Therapeutics?
Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism. Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
keywords:N/A
N/A
Total Funding
56
Number of Employees
$9.5M
Revenue (est)
56%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sitryx Therapeutics News
Eli Lilly immunometabolism partner Sitryx Therapeutics out of Oxford ... at Sobi before choosing a different path here at GSK-backed Sitryx.
Sitryx is a global biopharmaceutical company pioneering the field of immunometabolism. The company's proprietary platform and Product Engine are...
Other Companies in Oxford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 57 | 39% | N/A |
#2 | $11.5M | 58 | 9% | N/A |
#3 | N/A | 58 | -5% | N/A |
#4 | $8.7M | 59 | 28% | N/A |
#5 | $7.8M | 60 | 9% | N/A |